‹ Screener

RetinalGenix Technologies Inc.

RTGN · Surgical & Medical Instruments & Apparatus · 18.8M shares · +7%/yr ↑ shares · EDGAR filings ↗

Grade

F22

Dormant/near-insolvent micro-cap — deep losses (ROA -11542%) and effectively no liquidity.

Strengths

Risks

Notable findings

Key metrics

Return on equity
105.5%
Return on assets
-11542.2%
Current ratio
0.0×
Tangible book value
-$2M

Notable events (8-K)

DateItems
2026-03-26Exec/director changefiling ↗
2025-02-20Material agreementExhibitsfiling ↗
2024-04-08Otherfiling ↗
2023-12-06Exec/director changeExhibitsfiling ↗
2023-12-04Exec/director changeOtherExhibitsfiling ↗
2022-07-28Exec/director changefiling ↗
2022-07-07Material agreementAcquisition/disposition3.02OtherExhibitsfiling ↗
2022-02-17Material agreementExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
10-Q2026-05-202026-03-310001493152-26-024649 ↗
10-K2026-04-152025-12-310001493152-26-016638 ↗
8-K2026-03-262026-03-220001493152-26-012957 ↗
10-Q2025-11-142025-09-300001493152-25-023495 ↗
10-Q/A2025-08-202025-06-300001641172-25-024887 ↗
10-Q2025-08-192025-06-300001641172-25-024830 ↗
10-Q2025-05-152025-03-310001641172-25-010457 ↗
10-K2025-03-312024-12-310001641172-25-001788 ↗
8-K2025-02-202025-02-190001493152-25-007703 ↗
10-Q2024-11-182024-09-300001493152-24-046477 ↗
10-Q2024-08-192024-06-300001493152-24-033012 ↗
10-Q2024-05-202024-03-310001493152-24-020564 ↗